Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

Hypoxia-inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-derived Reactive Oxygen Species

Open access
Patten, David A., Lafleur, Véronique N., Robitaille, Geneviève A., Chan, Denise A., Giaccia, Amato J., Richard, Darren E. · 2010 · Molecular Biology of the Cell

Abstract

Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor for responses to low oxygen. Different nonhypoxic stimuli, including hormones and growth factors, are also important HIF-1 activators in the vasculature. Angiotensin II (Ang II), the main effecter hormone in the renin-angiotensin system, is a potent HIF-1 activator in vascular smooth muscle cells (VSMCs). HIF-1 activation by Ang II involves intricate mechanisms of HIF-1α transcription, translation, and protein stabilization. Additionally, the generation of reactive oxygen species (ROS) is essential for HIF-1 activation during Ang II treatment. However, the role of the different VSMC ROS generators in HIF-1 activation by Ang II remains unclear. This work aims at elucidating this question. Surprisingly, repression of NADPH oxidase-generated ROS, using Vas2870, a specific inhibitor or a p22 phox siRNA had no significant effect on HIF-1 accumulation by Ang II. In contrast, repression of mitochondrial-generated ROS, by complex III inhibition, by Rieske Fe-S protein siRNA, or by the mitochondrial-targeted antioxidant SkQ1, strikingly blocked HIF-1 accumulation. Furthermore, inhibition of mitochondrial-generated ROS abolished HIF-1α protein stability, HIF-1–dependent transcription and VSMC migration by Ang II. A large number of studies implicate NADPH oxidase–generated ROS in Ang II–mediated signaling pathways in VSMCs. However, our work points to mitochondrial-generated ROS as essential intermediates for HIF-1 activation in nonhypoxic conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1091/mbc.e10-01-0025

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. noxROS do not regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with VAS2870 (indicated concentrations) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α, phospho-p70S6K, total-p70S6K, and α-tubulin levels were then analyzed by Western blot. (B) VSMCs were transfected with a siRNA against p22phox or a control sequence. Quiescent VSMCs were treated or not with Ang II (100 nM) for 4 h. HIF-1α, p22phox, phospho-p70S6K, total-p70S6K, and α-tubulin levels were then analyzed by Western blot.
Figure 1. noxROS do not regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with VAS2870 (indicated concentrations) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α, phospho-p70S6K, total-p70S6K, and α-tubulin levels were then analyzed by Western blot. (B) VSMCs were transfected with a siRNA against p22phox or a control sequence. Quiescent VSMCs were treated or not with Ang II (100 nM) for 4 h. HIF-1α, p22phox, phospho-p70S6K, total-p70S6K, and α-tubulin levels were then analyzed by Western blot.CC BY-NC-SA · PubMed Central
Figure 2. mtROS regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with stigmatellin (Stig, 1 μM) or myxothiazol (Myx, 1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α and α-tubulin levels were analyzed by Western blot. (B) VSMCs were seeded on 35-mm glass-bottomed cell culture dishes and loaded with MitoSOX (1 μM) for 1 h. During the final 40 min, cells were pretreated or not with stigmatellin (1 μM) or myxothiazol (1 μM). Ang II (100 nM) was then added 20 min before imaging as described in Materials and Methods. Differential interference contrast microscopy (DIC) was used for whole cell imaging. Scale bars, 10 μm. Bottom panel is the quantification of results from B. Data are expressed as arbitrary units of MitoSOX fluorescence and are an average ± SD of five independent experiments, n > 50 cells. ***p < 0.001 compared with untreated VSMCs. †††p < 0.001 compared with Ang II–treated VSMCs.
Figure 2. mtROS regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with stigmatellin (Stig, 1 μM) or myxothiazol (Myx, 1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α and α-tubulin levels were analyzed by Western blot. (B) VSMCs were seeded on 35-mm glass-bottomed cell culture dishes and loaded with MitoSOX (1 μM) for 1 h. During the final 40 min, cells were pretreated or not with stigmatellin (1 μM) or myxothiazol (1 μM). Ang II (100 nM) was then added 20 min before imaging as described in Materials and Methods. Differential interference contrast microscopy (DIC) was used for whole cell imaging. Scale bars, 10 μm. Bottom panel is the quantification of results from B. Data are expressed as arbitrary units of MitoSOX fluorescence and are an average ± SD of five independent experiments, n > 50 cells. ***p < 0.001 compared with untreated VSMCs. †††p < 0.001 compared with Ang II–treated VSMCs.CC BY-NC-SA · PubMed Central
Figure 3. mtROS regulate HIF-1α accumulation. (A) VSMCs were transfected with a siRNA against Rieske Fe-S protein (100 nM) or a control sequence. Cells were then serum-deprived overnight and treated or not with Ang II (100 nM) for 4 h. HIF-1α, Rieske Fe-S protein, and α-tubulin levels were analyzed by Western blot. (B) VSMCs seeded on glass-bottomed cell culture dishes were transfected and treated as in A. Cellular mtROS levels were analyzed by MitoSOX staining as described in Figure 2. Scale bars, 10 μm.
Figure 3. mtROS regulate HIF-1α accumulation. (A) VSMCs were transfected with a siRNA against Rieske Fe-S protein (100 nM) or a control sequence. Cells were then serum-deprived overnight and treated or not with Ang II (100 nM) for 4 h. HIF-1α, Rieske Fe-S protein, and α-tubulin levels were analyzed by Western blot. (B) VSMCs seeded on glass-bottomed cell culture dishes were transfected and treated as in A. Cellular mtROS levels were analyzed by MitoSOX staining as described in Figure 2. Scale bars, 10 μm.CC BY-NC-SA · PubMed Central
Figure 4. mtROS regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with SkQ1 (500 nM) and then treated or not with Ang II (100 nM) for 4 h. HIF-1α, phospho p42/p44 MAPK, total p42/p44 MAPK and α-tubulin levels were analyzed by Western blot. (B) VSMCs seeded on glass-bottomed cell culture dishes were transfected and treated as in A. Cellular mtROS levels were analyzed by MitoSOX staining as described in Figure 2. Scale bars, 10 μm.
Figure 4. mtROS regulate HIF-1α accumulation. (A) Quiescent VSMCs were pretreated with SkQ1 (500 nM) and then treated or not with Ang II (100 nM) for 4 h. HIF-1α, phospho p42/p44 MAPK, total p42/p44 MAPK and α-tubulin levels were analyzed by Western blot. (B) VSMCs seeded on glass-bottomed cell culture dishes were transfected and treated as in A. Cellular mtROS levels were analyzed by MitoSOX staining as described in Figure 2. Scale bars, 10 μm.CC BY-NC-SA · PubMed Central
Figure 5. mtROS regulate HIF-1α half-life. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM) or myxothiazol (1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α half-life was measured by then treating cells with cycloheximide (30 μg/ml) for the indicated times to block all de novo protein synthesis. HIF-1α and α-tubulin levels were then analyzed by Western blot. (B) HIF-1α protein levels in A were quantified using the Odyssey Infrared Imaging System and normalized to α-tubulin. HIF-1α half-life was determined by plotting data as HIF-1α–α-tubulin ratio versus time under cycloheximide treatment. Data expressed are an average ± SEM of three independent experiments. **p < 0.01 compared with Ang II–treated VSMCs.
Figure 5. mtROS regulate HIF-1α half-life. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM) or myxothiazol (1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. HIF-1α half-life was measured by then treating cells with cycloheximide (30 μg/ml) for the indicated times to block all de novo protein synthesis. HIF-1α and α-tubulin levels were then analyzed by Western blot. (B) HIF-1α protein levels in A were quantified using the Odyssey Infrared Imaging System and normalized to α-tubulin. HIF-1α half-life was determined by plotting data as HIF-1α–α-tubulin ratio versus time under cycloheximide treatment. Data expressed are an average ± SEM of three independent experiments. **p < 0.01 compared with Ang II–treated VSMCs.CC BY-NC-SA · PubMed Central
Figure 6. mtROS regulate HIF-1α hydroxylation. Quiescent VSMCs were pretreated with stigmatellin (1 μM), myxothiazol (1 μM), or VAS2870 (10 μM) for 20 min. Cells were then treated with MG132 (20 μM) to increase HIF-1 levels and stimulated with Ang II (100 nM) or CoCl2 (200 μM) for 4 h. Nuclear extracts (100 μg) were analyzed by Western blot with anti-hydroxylated-Pro402-HIF-1α (P402-OH), anti-hydroxylated-Pro564-HIF-1α (P564-OH), anti-HIF-1α and anti-α-tubulin antibodies (top). Western blots in A were quantified with ImageJ or the Odyssey Infrared Imaging System using α-tubulin as a loading control (bottom panel). Results are expressed as a percentage of hydroxylated HIF-1 (normalized to total HIF-1α protein levels) on Pro402 (■) or Pro564 (▩) compared with untreated cells and are an average ± SEM of three independent experiments. **p < 0.01 and *p < 0.05 compared with untreated VSMCs.
Figure 6. mtROS regulate HIF-1α hydroxylation. Quiescent VSMCs were pretreated with stigmatellin (1 μM), myxothiazol (1 μM), or VAS2870 (10 μM) for 20 min. Cells were then treated with MG132 (20 μM) to increase HIF-1 levels and stimulated with Ang II (100 nM) or CoCl2 (200 μM) for 4 h. Nuclear extracts (100 μg) were analyzed by Western blot with anti-hydroxylated-Pro402-HIF-1α (P402-OH), anti-hydroxylated-Pro564-HIF-1α (P564-OH), anti-HIF-1α and anti-α-tubulin antibodies (top). Western blots in A were quantified with ImageJ or the Odyssey Infrared Imaging System using α-tubulin as a loading control (bottom panel). Results are expressed as a percentage of hydroxylated HIF-1 (normalized to total HIF-1α protein levels) on Pro402 (■) or Pro564 (▩) compared with untreated cells and are an average ± SEM of three independent experiments. **p < 0.01 and *p < 0.05 compared with untreated VSMCs.CC BY-NC-SA · PubMed Central
Figure 7. mtROS inhibit VHL-HIF-1α binding. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM), myxothiazol (1 μM), or VAS2870 (10 μM) for 20 min and subsequently treated or not with Ang II (100 nM) or CoCl2 for 4 h. Cytoplasmic extracts were incubated with GST-HIF-1α coupled to Sepharose beads for 1 h. Samples were then incubated in the presence of in vitro–translated pVHL and resolved by SDS-PAGE (12%). Immunoblotting was performed using anti-HA (pVHL) and anti-GST antibodies (A, top). Western blots were quantified with the Odyssey Infrared Imaging System using GST-HIF-1α as a loading control (A, bottom panel). Results are expressed as a percentage of pVHL binding normalized to GST-HIF-1α protein levels compared with untreated cells and are an average ± SEM of four independent experiments. **p < 0.01 and *p < 0.05 compared with untreated VSMCs. (B) VSMCs were transfected with a siRNA against p22phox or a control sequence. Quiescent VSMCs were treated or not with Ang II (100 nM) for 4 h. VHL-capture assay was then performed as in A.
Figure 7. mtROS inhibit VHL-HIF-1α binding. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM), myxothiazol (1 μM), or VAS2870 (10 μM) for 20 min and subsequently treated or not with Ang II (100 nM) or CoCl2 for 4 h. Cytoplasmic extracts were incubated with GST-HIF-1α coupled to Sepharose beads for 1 h. Samples were then incubated in the presence of in vitro–translated pVHL and resolved by SDS-PAGE (12%). Immunoblotting was performed using anti-HA (pVHL) and anti-GST antibodies (A, top). Western blots were quantified with the Odyssey Infrared Imaging System using GST-HIF-1α as a loading control (A, bottom panel). Results are expressed as a percentage of pVHL binding normalized to GST-HIF-1α protein levels compared with untreated cells and are an average ± SEM of four independent experiments. **p < 0.01 and *p < 0.05 compared with untreated VSMCs. (B) VSMCs were transfected with a siRNA against p22phox or a control sequence. Quiescent VSMCs were treated or not with Ang II (100 nM) for 4 h. VHL-capture assay was then performed as in A.CC BY-NC-SA · PubMed Central
Figure 8. mtROS are essential for HIF-1–dependent activity. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM) or myxothiazol (1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. Total RNA was extracted and resolved on formaldehyde/agarose gels. Northern blotting was performed using specific VEGF- and Glut-1–radiolabeled probes. An 18S RNA probe was used as a control for gel loading. Northern blots were quantified by phosphoimaging using total ribosomal 18S RNA as a loading control (Bottom panels). Data expressed are an average ± SEM of four independent experiments. ***p < 0.001 compared with untreated VSMCs. †p < 0.05 compared with Ang II–treated VSMCs. ‡Nonsignificant compared with Ang II–treated VSMCs.
Figure 8. mtROS are essential for HIF-1–dependent activity. (A) Quiescent VSMCs were pretreated with stigmatellin (1 μM) or myxothiazol (1 μM) for 20 min and then treated or not with Ang II (100 nM) for 4 h. Total RNA was extracted and resolved on formaldehyde/agarose gels. Northern blotting was performed using specific VEGF- and Glut-1–radiolabeled probes. An 18S RNA probe was used as a control for gel loading. Northern blots were quantified by phosphoimaging using total ribosomal 18S RNA as a loading control (Bottom panels). Data expressed are an average ± SEM of four independent experiments. ***p < 0.001 compared with untreated VSMCs. †p < 0.05 compared with Ang II–treated VSMCs. ‡Nonsignificant compared with Ang II–treated VSMCs.CC BY-NC-SA · PubMed Central
Figure 9. mtROS are essential for Ang II–dependent VSMC migration. VSMCs were transfected with a siRNA against HIF-1 or a control sequence (top) or left untransfected (bottom). Cells were serum-starved 24 h after transfection. Quiescent VSMCs (5 × 105 cells/well) were placed in the upper level of a Boyden chamber and allowed to migrate through a collagen-coated microporous membrane for 4 h toward the lower chamber that contained 100 nM Ang II in DMEM only (top) or in DMEM supplemented or not with stigmatellin (1 μM) or myxothiazol (1 μM; bottom). Cells were then fixed, stained, and counted as described in Materials and Methods. Data expressed are an average ± SEM of three independent experiments performed in triplicate. ***p < 0.001 compared with untreated (−) VSMCs.
Figure 9. mtROS are essential for Ang II–dependent VSMC migration. VSMCs were transfected with a siRNA against HIF-1 or a control sequence (top) or left untransfected (bottom). Cells were serum-starved 24 h after transfection. Quiescent VSMCs (5 × 105 cells/well) were placed in the upper level of a Boyden chamber and allowed to migrate through a collagen-coated microporous membrane for 4 h toward the lower chamber that contained 100 nM Ang II in DMEM only (top) or in DMEM supplemented or not with stigmatellin (1 μM) or myxothiazol (1 μM; bottom). Cells were then fixed, stained, and counted as described in Materials and Methods. Data expressed are an average ± SEM of three independent experiments performed in triplicate. ***p < 0.001 compared with untreated (−) VSMCs.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Research works printed but not linked: 3

  1. Andreyev A. Y., 2005, Biochemistry, 70, 200
  2. Antonenko Y. N., 2008, Biochemistry, 73, 1273
  3. Lambert C. M., 2010, Res

Cited by

See all 174

Metadata

Authors
Patten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E.
Affiliations
  • Centre hospitalier universitaire de Québec (CA)
  • Stanford Medicine (US)
Corresponding author
Richard, Darren E.
Venue
Molecular Biology of the Cell
Published
2010-09-15
Volume
21
Issue
18
Pages
3247-3257
ISSN
  • 1059-1524 (ISSN-L)
  • 1939-4586
OpenAlex
W2165725371
Cited by
171
References
78
Citations by year
2026: 2 · 2025: 5 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 6 · 2020: 11 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 13 · 2012: 19
FWCI
3.73
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Molecular Biology of the Cell (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
Funders
  • Canadian Institutes of Health Research (102760_1, MOP-49609)
  • National Cancer Institute (R37CA088480)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
HIF-1, HIF-1α stabilization, angiotensin II, vascular smooth muscle cells, mitochondrial reactive oxygen species, NADPH oxidase, complex III inhibition, Rieske iron-sulfur protein, SkQ1, cell migration, renin-angiotensin system
MeSH terms
Angiotensin II, Animals, Anti-Bacterial Agents, Antifungal Agents, Cells, Cultured, Male, Methacrylates, Mitochondria, Muscle, Smooth, Vascular, Polyenes, Thiazoles, Electron Transport Complex III, Rats, Wistar, Reactive Oxygen Species, NADPH Oxidases, Mitogen-Activated Protein Kinase 1, Myocytes, Smooth Muscle, RNA, Small Interfering, Mitogen-Activated Protein Kinase 3, Rats, Hypoxia-Inducible Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia-inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-derived Reactive Oxygen Species. https://app.cochat.ai/papers/10.1091/mbc.e10-01-0025
The paper
Patten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E. (2010). Hypoxia-inducible Factor-1 Activation in Nonhypoxic Conditions: The Essential Role of Mitochondrial-derived Reactive Oxygen Species. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e10-01-0025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.